SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form NT 10-Q - Notification of inability to timely file Form 10-Q or 10-QSB:
SEC Accession No. 0001683168-24-002385
Filing Date
2024-04-15
Accepted
2024-04-15 10:35:15
Documents
1
Period of Report
2024-02-29
Effectiveness Date
2024-04-15

Document Format Files

Seq Description Document Type Size
1 EXTENSION cnbx_ext.htm NT 10-Q 18852
  Complete submission text file 0001683168-24-002385.txt   20267
Mailing Address #3 BETHESDA METRO CENTER SUITE 700 BETHESDA MD 20814
Business Address #3 BETHESDA METRO CENTER SUITE 700 BETHESDA MD 20814 877-424-2429
CNBX Pharmaceuticals Inc. (Filer) CIK: 0001343009 (see all company filings)

IRS No.: 203373669 | State of Incorp.: NV | Fiscal Year End: 0831
Type: NT 10-Q | Act: 34 | File No.: 000-52403 | Film No.: 24843423
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)